Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at ...
1 The authors describe a man aged 76 years who developed recurrent venous thrombosis despite anticoagulation and progressive bilateral pulmonary artery aneurysms. Hughes Stovin syndrome-related ...
The interim results from the Phase 1b open label clinical trial are based on 16 of 19 enrolled patients with PH-HFpEF, with the remaining 3 patients currently completing Part A of the protocol ...
TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF ...
WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), today announced positive interim data from the Phase 1b acute hemodynamic clinical ...
Dietary impact on pulmonary pressures is still poorly understood, but it seems that micronutrient deficiency could be a rare cause of pulmonary hypertension ... investigations revealed cardiomegaly on ...
TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction ("PH-HFpEF”), supporting ...
MANILA, Philippines — DoubleDragon Corp., the listed property developer owned by Edgar “Injap” Sia II and Tony Tan Caktiong, is bolstering significantly its war chest with capital-raising ...
This new kidney-targeted treatment is offering hope to hypertension patients by disrupting overactive renal nerves and lowering stubbornly high blood pressure. Nothing doctors prescribed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results